Drummond, Sculpher, Claxton, Stoddart, Torrance · Oxford University Press
The standard reference text for health economic evaluation. Covers cost-effectiveness, cost-utility, and cost-benefit analysis with worked examples from international HTA practice.
The authoritative methodological reference for technology appraisal submissions to NICE England. Defines acceptable evidence standards for cost-per-QALY submissions.
Briggs, Sculpher, Claxton · Oxford University Press
A rigorous treatment of decision-analytic modelling for health economics, covering Markov models, probabilistic sensitivity analysis, and value of information methods.
A series of consensus statements covering best practices in health technology assessment modelling, indirect treatment comparisons, and budget impact analysis.
Economic Modelling
Evidence Synthesis
HTA & Policy
Journal Article
2020
Measuring and Valuing Health: EQ-5D and NICE Reference Case
Health Technology Assessment
Examines the EQ-5D instrument as the preferred measure for deriving utility weights in cost-utility analysis, with commentary on mapping algorithms and tariff selection.
An accessible summary of how GBD disability weights and DALYs relate to health economic evaluation, including cross-country comparisons of burden by disease category.
Free access to recorded presentations from ISPOR's annual and European congresses, covering advances in modelling, real-world evidence, and HTA policy.
Archive of Health Technology Assessment International webinars on topics from patient involvement in HTA to adaptive pathways and managed entry agreements.
Interviews with leading health economists and HEOR practitioners. Episodes cover value demonstration, digital health economics, and market access strategy.
Recorded public lectures from CHE York on cost-effectiveness thresholds, opportunity cost, and the social value of health. Rigorous and policy-relevant.
Short-form videos explaining NICE's tiered evidence standards for digital health technologies, including how AI and algorithm-driven devices are evaluated.
HTA & Policy
Evidence Synthesis
Tools & Resources
Software, databases, calculators, templates, and open decision models.
Open-source R package for building Markov and partitioned survival models. Supports deterministic and probabilistic sensitivity analysis, EVPI, and value of information.
Repository of publicly available decision-analytic models from the University of Oxford HERC group, covering musculoskeletal conditions, mental health, and vaccines.
Standardised cost-effectiveness estimates for more than 700 health interventions across 14 sub-regions, facilitating cross-country comparisons using generalised CEA.
Official EuroQol mapping and crosswalk tools for converting EQ-5D-3L to EQ-5D-5L utility scores, applying national value sets, and estimating QALYs in trial analyses.
Searchable repository of completed health technology assessments from INAHTA member agencies, maintained by York's Centre for Reviews and Dissemination.
HTA & Policy
Evidence Synthesis
Template
2021
PSA Toolkit for Excel — probabilistic sensitivity analysis
An open Excel template implementing common PSA distribution families (beta, gamma, log-normal, Dirichlet) with Monte Carlo sampling and cost-effectiveness plane output.
A series of authoritative technical guides covering network meta-analysis, survival modelling, partitioned survival models, and costing in NICE submissions.